Inbrija 42 mg/1 (Levodopa CAPSULE) 42 mg/1

Inbrija 42 mg/1 capsules provide a convenient inhalation route for levodopa, a key component in managing Parkinson's disease symptoms. This formulation is designed for respiratory use, offering an alternative to traditional oral administration.

Strength

42 mg/1

Pack Size

3 BLISTER PACK in 1 CARTON (10144-342-12) / 4 CAPSULE in 1 BLISTER PACK (10144-342-01)

Manufacturer / TM Owner

Merz Pharmaceuticals, LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Inbrija 42 mg/1 capsules are primarily used for the treatment of Parkinson's disease. Levodopa, the active ingredient, helps to replenish dopamine levels in the brain, which can alleviate symptoms such as tremors, stiffness, and difficulty moving. This formulation is particularly useful for individuals who experience fluctuations in their symptoms throughout the day.

Side Effects

Common effects of Inbrija 42 mg/1 capsules may include improvements in motor function and a reduction in Parkinson's disease symptoms. Some users may experience temporary side effects such as nausea, dizziness, or dry mouth. These effects can vary widely among individuals.

Precautions & Warnings

Inbrija 42 mg/1 capsules should be used under the guidance of a healthcare professional. It is important to follow the prescribed dosage and administration instructions carefully. Patients with a history of certain respiratory conditions should consult their doctor before using this medication.

Avoid Interactions

Inbrija 42 mg/1 capsules may interact with other medications, including those that affect dopamine levels or are metabolized by the liver. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be discussed with a healthcare professional.

Frequently Asked Questions

Inbrija 42 mg/1 capsules are used to manage symptoms of Parkinson's disease, such as tremors and stiffness, by providing a respiratory route for levodopa.

Inbrija 42 mg/1 capsules deliver levodopa through inhalation, which is then converted into dopamine in the brain to help alleviate Parkinson's disease symptoms.

Common side effects may include nausea, dizziness, and dry mouth. These effects can vary among individuals.

Inbrija 42 mg/1 may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Inbrija 42 mg/1 is designed for specific use cases in Parkinson's disease management. Consult a healthcare professional to determine if it is appropriate for your condition.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.